CheMedImmune

CheMedImmune

Pre-clinical
Cambridge, United StatesFounded 2018chemedimmune.com

Develops immunotherapies and antibody-based therapeutics for cancer and autoimmune diseases.

Market Cap
Private
Pipeline
Patents
Publications

Private Company

Funding information not available

About

Develops immunotherapies and antibody-based therapeutics for cancer and autoimmune diseases.

AntibodiesBiologicsCell & Gene Therapy